Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 113

1.

The impact of eliminating age inequalities in stage at diagnosis on breast cancer survival for older women.

Rutherford MJ, Abel GA, Greenberg DC, Lambert PC, Lyratzopoulos G.

Br J Cancer. 2015 Mar 31;112 Suppl:S124-8. doi: 10.1038/bjc.2015.51.

2.

Estimating the potential survival gains by eliminating socioeconomic and sex inequalities in stage at diagnosis of melanoma.

Rutherford MJ, Ironmonger L, Ormiston-Smith N, Abel GA, Greenberg DC, Lyratzopoulos G, Lambert PC.

Br J Cancer. 2015 Mar 31;112 Suppl:S116-23. doi: 10.1038/bjc.2015.50.

3.

Understanding the impact of socioeconomic differences in breast cancer survival in England and Wales: avoidable deaths and potential gain in expectation of life.

Rutherford MJ, Andersson TM, Møller H, Lambert PC.

Cancer Epidemiol. 2015 Feb;39(1):118-25. doi: 10.1016/j.canep.2014.11.002. Epub 2014 Nov 28.

PMID:
25435402
4.

A general framework for parametric survival analysis.

Crowther MJ, Lambert PC.

Stat Med. 2014 Dec 30;33(30):5280-97. doi: 10.1002/sim.6300. Epub 2014 Sep 15.

PMID:
25220693
5.

Franz Kafka and the doctor's dilemma.

Lambert WC, Wassef C, Lambert PC.

Skinmed. 2014 May-Jun;12(3):139. No abstract available.

PMID:
25136737
6.

New wine in old bottles: the coming deluge of aggressive cutaneous cancers and precancers.

Wassef C, Lee B, Lambert PC, Patel L, Lambert WC.

Skinmed. 2014 May-Jun;12(3):183-5. No abstract available.

PMID:
25134315
7.

The application of cure models in the presence of competing risks: a tool for improved risk communication in population-based cancer patient survival.

Eloranta S, Lambert PC, Andersson TM, Björkholm M, Dickman PW.

Epidemiology. 2014 Sep;25(5):742-8. doi: 10.1097/EDE.0000000000000130.

PMID:
25036430
8.

The sign of Leser-Trélat: is it really so?--for your eyes only.

Lavery MJ, Parish LC, Lambert PC, Lee RE, Lambert WC.

Skinmed. 2014 Mar-Apr;12(2):76-8. No abstract available.

PMID:
24933843
9.

Serum selenium in relation to measures of glucose metabolism and incidence of Type 2 diabetes in an older Swedish population.

Gao H, Hägg S, Sjögren P, Lambert PC, Ingelsson E, van Dam RM.

Diabet Med. 2014 Jul;31(7):787-93. doi: 10.1111/dme.12429. Epub 2014 Mar 28.

PMID:
24606531
10.

Adjusting survival time estimates to account for treatment switching in randomized controlled trials--an economic evaluation context: methods, limitations, and recommendations.

Latimer NR, Abrams KR, Lambert PC, Crowther MJ, Wailoo AJ, Morden JP, Akehurst RL, Campbell MJ.

Med Decis Making. 2014 Apr;34(3):387-402. doi: 10.1177/0272989X13520192. Epub 2014 Jan 21.

PMID:
24449433
11.

Estimating the cure proportion of malignant melanoma, an alternative approach to assess long term survival: a population-based study.

Andersson TM, Eriksson H, Hansson J, Månsson-Brahme E, Dickman PW, Eloranta S, Lambe M, Lambert PC.

Cancer Epidemiol. 2014 Feb;38(1):93-9. doi: 10.1016/j.canep.2013.12.006. Epub 2014 Jan 18.

PMID:
24447700
12.

Atypia without pleomorphism and atypia without atypia: when you can't even see the trees for the trees.

Harmon G, Lambert PC, Katava GL, Lambert WC.

Skinmed. 2013 Sep-Oct;11(5):291-3. No abstract available.

PMID:
24340469
13.

Familial coaggregation of Alzheimer's disease and Parkinson's disease: systematic review and meta-analysis.

Feldman AL, Johansson AL, Lambert PC, Sieurin J, Yang F, Pedersen NL, Wirdefeldt K.

Neuroepidemiology. 2014;42(2):69-80. doi: 10.1159/000355452. Epub 2013 Nov 30. Review.

14.

Adjusting for measurement error in baseline prognostic biomarkers included in a time-to-event analysis: a joint modelling approach.

Crowther MJ, Lambert PC, Abrams KR.

BMC Med Res Methodol. 2013 Dec 1;13:146. doi: 10.1186/1471-2288-13-146.

15.

Estimating the proportion cured of cancer: some practical advice for users.

Yu XQ, De Angelis R, Andersson TM, Lambert PC, O'Connell DL, Dickman PW.

Cancer Epidemiol. 2013 Dec;37(6):836-42. doi: 10.1016/j.canep.2013.08.014. Epub 2013 Sep 14.

PMID:
24042025
16.

Estimating the loss in expectation of life due to cancer using flexible parametric survival models.

Andersson TM, Dickman PW, Eloranta S, Lambe M, Lambert PC.

Stat Med. 2013 Dec 30;32(30):5286-300. doi: 10.1002/sim.5943. Epub 2013 Aug 23.

PMID:
24038155
17.

Bed occupancy rates and hospital-acquired Clostridium difficile infection: a cohort study.

Ahyow LC, Lambert PC, Jenkins DR, Neal KR, Tobin M.

Infect Control Hosp Epidemiol. 2013 Oct;34(10):1062-9. doi: 10.1086/673156. Epub 2013 Aug 23.

PMID:
24018923
18.

Anonymous dermatopathologists: a socioeconomic solution to a medical problem.

Wassef C, Lambert PC, Gagna CE, Harmon G, Lambert WC.

Skinmed. 2013 May-Jun;11(3):167-9. No abstract available.

PMID:
23930356
19.

Survival and cure of acute myeloid leukaemia in England, 1971-2006: a population-based study.

Shah A, Andersson TM, Rachet B, Björkholm M, Lambert PC.

Br J Haematol. 2013 Aug;162(4):509-16. doi: 10.1111/bjh.12425. Epub 2013 Jun 21.

PMID:
23786647
20.

Modelling time to death or discharge in neonatal care: an application of competing risks.

Hinchliffe SR, Seaton SE, Lambert PC, Draper ES, Field DJ, Manktelow BN.

Paediatr Perinat Epidemiol. 2013 Jul;27(4):426-33. doi: 10.1111/ppe.12053. Epub 2013 Apr 15.

PMID:
23772944
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk